Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Desflurane on PARDS after LDLT
NCT05783518Phase 4Unknown
- Sponsor
- Tianjin First Central Hospital
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of desflurane in biliary atresia (3 arms), sponsored by Tianjin First Central Hospital. Primary endpoint: Incidence of Pediatric Acute Respiratory Distress Syndrome at 7 days. Status: unknown.
02
Drugs
desflurane
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT05783518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05783518.